Rhumbline Advisers Astellas Pharma Inc Unsponsore Call Options Transaction History
Rhumbline Advisers
- $103 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding ALPMY
# of Institutions
6Shares Held
42.8KCall Options Held
0Put Options Held
0-
Gamma Investing LLC Foster City, CA3.31KShares$33,0560.0% of portfolio
-
Private Capital Group, LLC1.09KShares$10,8490.01% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA307Shares$3,0660.0% of portfolio
-
Operose Advisors LLC Milwaukee, WI90Shares$8990.0% of portfolio
-
First Horizon Advisors, Inc.37Shares$3690.0% of portfolio
About Astellas Pharma Inc Unsponsore
- Ticker ALPMY
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,827,069,952
- Market Cap $18.3B